p27(Kip1) expression by contact inhibition as a prognostic index of human glioma

Journal of Neurochemistry

Volumn 74, Issue 4, 2000, Pages 1393-1399

  Fuse, Takahisa ^a   Tanikawa, Motoki ^a,b   Nakanishi, Makoto ^a,b   Ikeda, Kyoji ^b   Tada, Toyohiro ^a   Inagaki, Hiroshi ^a   Asai, Kiyofumi ^a   Kato, Taiji ^a   Yamada, Kazuo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Cell cycle; Contact inhibition; Glioma; P27(Kip1); Prognostic index

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; KI 67 ANTIGEN; PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTACT INHIBITION; CONTROLLED STUDY; DNA CONTENT; GENE EXPRESSION REGULATION; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; CELL CULTURE; CELL CYCLE; CELL DIVISION; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; GLIOBLASTOMA; METABOLISM; MORTALITY; NORTHERN BLOTTING; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SURVIVAL;

BLOTTING, NORTHERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CONTACT INHIBITION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033622111     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0741393.x     Document Type: Article

References (24)

1. Abercrombie M. (1979) Contact inhibition and malignancy. Nature 281, 259-262.
2. Catzavelos C., Bhattacharya N., Ung Y. C., Wilson J. A., Roncari L., Sandhu C., Shaw P., Yeger H., Morava-Protzner I., Kapusta L., Franssen E., Pritchard K. I., and Slingerland J. M. (1997) Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3, 227-230.
3. Craig C., Wersto R., Kim M., Ohri E., Li Z., Katayose D., Lee S. J., Trepel J., Cowan K., and Seth P. (1997) A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14, 2283-2289.
4. Daduang S., Kimura K., Nagata S., and Fukui Y. (1998) Density dependent elevation of phosphatidylinositol-3-kinase level in rat 3Y1 cells. Biochim. Biophys. Acta 1401, 113-120.
5. De Ridder L. I., Laerum O. D., Mork S. J., and Bigner D. D. (1987) Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathol. (Berl.) 72, 207-213.
6. Dietrich C., Wallenfang K., Oesch F., and Wieser R. (1997) Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene 15, 2743-2747.
7. Hengst L. and Reed S. I. (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861-1864.
8. Kawada M., Uehara Y., Mizuno S., Yamori T., and Tsuruo T. (1998) Up-regulation of p27Kip1 correlates inversely with anchorage-independent growth of human cancer cell lines. Jpn. J. Cancer Res. 89, 110-115.
9. Kringer M. (1990) Gene Transfer and Expression: A Laboratory Manual, pp. 96-98. Stockton Press, New York.
10. Loda M., Cukor B., Tam S. W., Lavin P., Fiorentino M., Draetta G. F., Jessup J. M., and Pagano M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3, 231-234.
11. Moreton K., Turner R., Blake N., Paton A., Groome N., and Rumshy M. (1995) Protein expression of the alpha, gamma, delta and epsilon subspecies of protein kinase C changes as C6 glioma cells become contact inhibited and quiescent in the presence of serum. FEBS Lett. 372, 33-38.
12. Mori M., Mimori K., Shiraishi T., Tanaka S., Ueo H., Sugimachi K., and Akiyoshi T. (1997) p27 expression and gastric carcinoma. Nat. Med. 3, 593.
13. Naumann U., Weit S., Rieger L., Meyermann R., and Weller M. (1999) p27 modulates cell cycle progression and chemosensitivity in human malignant glioma. Biochem. Biophys. Res. Commun. 261, 890-896.
14. Piva R., Cavalla P., Bortolotto S., Cordera S., Richiardi P., and Schiffer D. (1997) p27/kip1 expression in human astrocytic gliomas. Neurosci. Lett. 234, 127-130.
15. Piva R., Cancelli I., Cavella P., Bortolotto S., Dominguez J., Draetta G. F., and Schiffer D. (1999) Proteasome-dependent degradation of p27/kip1 in gliomas. J. Neuropathol. Exp. Neurol. 58, 691-696.
16. Polyak K., Kato J. K., Solomon M. J., Sherr C. J., Massague J., Roberts J. M., and Koff A. (1994a) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
17. Polyak K., Lee M.-H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., and Massague J. (1994b) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
18. Porter P. L., Malone K. E., Heagerty P. J., Alexander G. M., Gatti L. A., Firpo E. J., Daling J. R., and Roberts J. M. (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3, 222-225.
19. Sambrook J., Fritch E. F., and Maniatis T., eds (1989) Molecular Cloning, A Laboratory Manual. 2nd edit. Cold Spring Harbor Laboratory Press. New York.
20. Schiffer D., Bortolotto S., Bosone I., Cancelli I., Cavalla P., Schiffer P., and Piva R. (1999) Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. Neurosci. Lett. 264, 29-32.
21. Stein G. H. (1979) T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J. Cell. Physiol. 99, 43-54.
22. Tanikawa M., Yamada K., Tominaga K., Morisaki H., Kaneko Y., Ikeda K., Suzuki M., Kiho T., Tomokiyo K., Furuta K., Noyori R., and Nakanishi M. (1998) Potent prostaglandin A1 analogs that suppress tumor cell growth through induction of p21 and reduction of cyclin E. J. Biol. Chem. 273, 18522-18527.
23. Wang Q. M., Jones J. B., and Studzinski G. P. (1996) Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56, 264-267.
24. Yang R. M., Naitoh J., Murphy M., Wang H.-E., Phillipson J., de-Kernion J. B., Loda M., and Reiter R. E. (1998) Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941-945.